tiprankstipranks
Bright Minds Biosciences (DRUG)
NASDAQ:DRUG
US Market
DRUG
Bright Minds Biosciences
RESEARCH TOOLSreports

Bright Minds Biosciences (DRUG) Ratios

280 Followers

Bright Minds Biosciences Ratios

DRUG's free cash flow for Q1 2026 was C$0.00. For the 2026 fiscal year, DRUG's free cash flow was decreased by C$ and operating cash flow was C$0.00. See a summary of the company’s cash flow.
Ratios
TTM
Sep 25Dec 24Sep 23Sep 22
Liquidity Ratios
Current Ratio
 57.37 36.10 11.32 24.26 8.11
Quick Ratio
 57.37 36.10 11.32 24.26 8.11
Cash Ratio
 56.27 35.50 10.82 24.03 7.90
Solvency Ratio
 -12.36 -5.11 -4.80 -25.99 -9.83
Operating Cash Flow Ratio
 -8.22 -3.72 -3.50 -25.01 -9.23
Short-Term Operating Cash Flow Coverage
 0.00 0.00 -23.31 0.00 0.00
Net Current Asset Value
C$ 89.19MC$ 81.93MC$ 5.42MC$ 6.53MC$ 10.40M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 <0.01 0.02 0.01 0.01
Debt-to-Equity Ratio
 <0.01 <0.01 0.02 0.01 0.01
Debt-to-Capital Ratio
 <0.01 <0.01 0.02 0.01 0.01
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.02 1.03 1.10 1.04 1.15
Debt Service Coverage Ratio
 -2.66K -386.62 -30.79 -368.61 -67.10
Interest Coverage Ratio
 -2.63K -388.76 -314.57 -373.00 -66.17
Debt to Market Cap
 0.00 0.00 0.01 0.00 0.00
Interest Debt Per Share
 0.01 0.02 0.03 0.03 0.15
Net Debt to EBITDA
 4.65 5.97 2.06 0.92 0.78
Profitability Margins
Gross Profit Margin
0.00%0.00%0.00%0.00%0.00%
EBIT Margin
0.00%0.00%0.00%0.00%0.00%
EBITDA Margin
0.00%0.00%0.00%0.00%0.00%
Operating Profit Margin
0.00%0.00%0.00%0.00%0.00%
Pretax Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Profit Margin
0.00%0.00%0.00%0.00%0.00%
Continuous Operations Profit Margin
0.00%0.00%0.00%0.00%0.00%
Net Income Per EBT
100.00%100.00%100.00%100.00%101.49%
EBT Per EBIT
103.26%87.74%99.58%100.08%101.51%
Return on Assets (ROA)
-21.84%-14.49%-45.90%-107.17%-125.65%
Return on Equity (ROE)
-28.46%-14.91%-50.61%-111.73%-144.06%
Return on Capital Employed (ROCE)
-21.52%-16.98%-50.46%-111.65%-138.89%
Return on Invested Capital (ROIC)
-21.50%-16.96%-49.07%-110.42%-138.00%
Return on Tangible Assets
-21.84%-14.49%-45.90%-107.17%-125.65%
Earnings Yield
-2.21%-2.11%-44.22%-92.20%-72.33%
Efficiency Ratios
Receivables Turnover
 0.00 0.00 0.00 0.00 0.00
Payables Turnover
 0.04 0.04 0.18 0.40 <0.01
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Asset Turnover
 0.00 0.00 0.00 0.00 0.00
Working Capital Turnover Ratio
 0.00 0.00 0.00 0.00 0.00
Cash Conversion Cycle
 -9.44K -8.12K -2.03K -918.45 -75.36K
Days of Sales Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 9.44K 8.12K 2.03K 918.45 75.36K
Operating Cycle
 0.00 0.00 0.00 0.00 0.00
Cash Flow Ratios
Operating Cash Flow Per Share
 -1.68 -1.26 -0.43 -1.89 -5.50
Free Cash Flow Per Share
 -1.68 -1.26 -0.43 -1.89 -5.50
CapEx Per Share
 <0.01 0.00 <0.01 <0.01 0.00
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -2.60M 0.00 -462.55K -1.40M 0.00
Capital Expenditure Coverage Ratio
 -2.60M 0.00 -462.55K -1.40M 0.00
Operating Cash Flow Coverage Ratio
 -124.05 -69.10 -15.55 -95.50 -97.11
Operating Cash Flow to Sales Ratio
 0.00 0.00 0.00 0.00 0.00
Free Cash Flow Yield
-1.45%-1.50%-29.20%-87.85%-64.71%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -45.24 -47.46 -2.26 -1.08 -1.38
Price-to-Sales (P/S) Ratio
 0.00 0.00 0.00 0.00 0.00
Price-to-Book (P/B) Ratio
 10.05 7.07 1.14 1.21 1.99
Price-to-Free Cash Flow (P/FCF) Ratio
 -68.98 -66.78 -3.42 -1.14 -1.55
Price-to-Operating Cash Flow Ratio
 -68.98 -66.78 -3.42 -1.14 -1.55
Price-to-Earnings Growth (PEG) Ratio
 0.79 -0.27 0.03 0.02 -0.05
Price-to-Fair Value
 10.05 7.07 1.14 1.21 1.99
Enterprise Value Multiple
 -42.25 -35.90 -0.27 -0.18 -0.65
Enterprise Value
 808.75M 497.66M 734.81K 1.32M 9.51M
EV to EBITDA
 -42.25 -35.90 -0.27 -0.18 -0.65
EV to Sales
 0.00 0.00 0.00 0.00 0.00
EV to Free Cash Flow
 -62.15 -57.26 -0.40 -0.19 -0.70
EV to Operating Cash Flow
 -62.15 -57.26 -0.40 -0.19 -0.70
Tangible Book Value Per Share
 11.50 11.93 1.28 1.77 4.27
Shareholders’ Equity Per Share
 11.50 11.93 1.28 1.77 4.27
Tax and Other Ratios
Effective Tax Rate
 -0.01 0.00 0.00 0.00 -0.01
Revenue Per Share
 0.00 0.00 0.00 0.00 0.00
Net Income Per Share
 -2.56 -1.78 -0.65 -1.98 -6.15
Tax Burden
 1.00 1.00 1.00 1.00 1.01
Interest Burden
 1.03 0.88 1.00 1.00 1.02
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.66 0.71 0.66 0.95 0.91
Currency in CAD